The MD&M West Conference Feb. 5-7 in Anaheim, CA will feature a curated roster of speakers with deeply-technical expertise in everything from new technology and next-generation design, to product development, new materials, product testing, and quality.
The San Clemente, CA-based firm is developing several glaucoma treatment products as it transitions into a hybrid surgical, pharmaceutical, and medical device company.
A half-day workshop at MD&M West will give attendees the chance to interact with both patients and new technologies. The session can help designers and engineers rapidly understand user needs and how empathy and co-creation can occur even within compressed schedules.
The San Francisco-based company and developer of the Zio Patch is set to present at the 37th Annual J.P. Morgan Healthcare Conference this week.
The New Year offers the chance to review your company’s marketing and sales practices given recent enforcement activity
A recently-published meta-analysis showed higher mortality rates with Paclitaxel drug-coated balloons and drug-eluting stents, and at least two drug-eluting device trials have been paused.
Boston Scientific is Editor’s Choice for 2018 Company of the Year because of its numerous acquisitions, meticulous planning, and its unwillingness to stay silent when tackling controversy. The Marlborough, MA-based company is on the cusp of change.
There has been a lot of buzz about Apple's foray into healthcare and reports of the company hiring "dozens" of medical doctors, but what does that actually mean for medtech?
A drug-delivery device expert shares how advances in technology, digital health, and data protection could help patients better manage their drug regimens.
Ernst & Young resigned as MiMedx's outside auditor after advising the company that the internal controls necessary for MiMedx to develop reliable financial statements do not exist.
The EU regulation may have been around for more than a decade, but there is still a lot for medtech to learn.